Connect with us

Emerging Markets

Hiru Corp. (OTCMKTS: HIRU) Steady Run Northbound as ICE Co Reduces Share Structure, Reports Record Q2 Revenues & Applies for SQF Certification

Published

10 months ago

on

Hiru Corp. (OTCMKTS: HIRU) continues to move higher with power in recent trading looking to breakout into copperland as more investors jump on board and the heavy accumulation continues. HIRU has been getting noticed ever since new CEO Kathryn Gavin took over the Company with extensive experience in commercial water and ice manufacturing, production, and sale as described under S.I.C. Code 4981 (Water Supply) and S.I.C. Code 2097 (Manufactured Ice). Since her arrival in Arizona, Ms. Gavin has researched, located, and is in current negotiations to acquire several high-profile cash flow positive business operations in the State of Arizona in these two particulars S.I.C. code industries which she plans to bring to the public markets through the HIRU Corporation.  

HIRU just announced 2nd quarter ended revenues of over $2,800,000 USD with a quarterly net profit of $1,359,005 USD. The Company expects to beat its predicted annual 2022 top line revenue of $10,000,000 USD at the close of this fiscal year. HIRU is now reaching its full operational potential which has proven that our decision to dramatically increase its automated water bottling line capabilities last summer was the correct course of action. The Company expects to produce in excess of $4,000,000 USD for the 3rd quarter ended June 30, 2022, and between $6,000,000 USD to $8,000,000 USD for the 4th quarter ended December 31, 2022. That will result in an annual revenue of between $14,000,000 USD to $16,000,000 USD for calendar year ended December 31, 2022. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Hiru Corp. (OTCMKTS: HIRU) operating out of Phoenix, Arizona is a public quoted pink Sheet issuer under the ticker symbol “HIRU”. HIRU reports as an alternative reporting issuer with OTC Markets Group, Inc. and is current in its mandatory required filings. HIRU operates its flagship property is the Water & Ice Shop offering consumers across Arizona with bagged ice and bottled water. In Phoenix, Arizona the Company has cutting-edge commercial water bottling and labeling facility.

Hiru is completely equipped to manage all of its customers’ demands, with a daily production capacity of about 100 tons of tubed ice and a well-maintained fleet of over 10 refrigerated trucks and trailers. The Company provides weekly route service to its reselling partners and works carefully to manage all of your unique events and occasions, seven days a week. Water & Ice Shop is happy to rent its Freezer Boxes and Trailers for all of your special events, and we offer white glove service for all of your Bagged Ice and Bottled Water needs. All of Water & Ice Shop retail clients receive dedicated weekly servicing at a minimum, ensuring that they are never out of merchandise. Water & Ice Shop ensures that several deliveries are made as needed, taking into account seasonality and client demands. A well-trained crew of drivers and assistance manage a huge fleet of refrigerated trucks and trailers.  

Earlier this year HIRU announced significant new production capacity through new co-packing partner, AZ Custom Bottled Water, LLC. AZ Custom Water completed a new packaging and bottling line in 2021 and is further expanding capacity and capabilities in 2022. The Company’s strategic network of copackers has allowed it to produce and deliver when many of its competitors could not. Now, with the addition of AZ Custom Water and their production capabilities, the Company is further strengthening its position in the Southwest. This year, AZ Custom Water will be an important producer of the Company’s entire portfolio of water products, including being its west coast supplier for the Company’s growing line of Alkaline88® FreshCap™ functional beverages. As we grow, we are finding the need for multiple bottlers in strategic markets.  

Kathryn Gavin was named as the new sole officer and director of the Company in March. Ms. Gavin has had numerous professional management positions during her career including being the former sole officer and director of UMAX Group Corp., a Nevada corporation, a pink sheet company trading under the ticker symbol “UMAX. This new industry focus was the impetus to her moving to Scottsdale, Arizona in the Summer of 2020. (SHE MOVED HERE SOLELY TO FOCUS ON HIRU….) Since her arrival in Arizona, Ms. Gavin has researched, located, and is in current negotiations to acquire several high-profile cash flow positive business operations in the State of Arizona in these two particulars S.I.C. code industries which she plans to bring to the public markets through the HIRU Corporation.  

In May HIRU leased its fourth facility to bottle water. The New Facility is 51,000 square feet and is located in Glendale, Arizona. It will be able to house up to 5 new automated water bottling lines and have enough room to have a finished good storage contained therein. Additionally, there are 7 commercial delivery truck loading bays to make ease of delivery to the Company’s clients a priority. Hiru is currently building out the initial Bottling Line in the New Facility to meet its expected future demand for co-packed water products. The Company is also moving two of its automated lines to this New Facility as well.  The ultimate annual capacity of each Bottling Line in the New Facility is 36,000 gallon bottles a day or 1,080,000 gallon bottles a month.  Three of the new Bottling Lines in the New Facility are to be reserved for our co-packing contract with the previously announced relationship with a national bottled water retailer.  This New Facility will also produce gallon, liter, and half liter water bottles for several new purchase orders from new clients the Company is expected to provide during the third and fourth quarter of 2022. 

To Find out the inside Scoop on HIRU Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

HIRU

HIRU has been making some big moves recently applying for its SQF Certification so that the Company may start co-packing for Walmart, Inc. and other larger retail outlets. A SQF Certification is a program to verify safe foods and is part of a comprehensive HACCP-based food safety and quality management certification system. It is the first step towards a wholesale manufacturer receiving product orders from retail outlets. The SQF Program is recognized by foodservice providers and retailers around the world who require a rigorous and credible food safety management system. Benchmarked to Global Food Safety Initiative (GFSI) standards, SQF links primary production certification to food manufacturing, distribution, and retail certification.  

The Company anticipates receiving this SQF Certification shortly. At that point, we will become a co-packer for Walmart and will receive orders on a regular basis.  This will be a huge event for the Company with regards to top line revenue related to our production of water products for resale to other potential retail operations as well. As soon as the SQF Certification is issued, the Company will make a public announcement.   

HIRU also has come to terms with a shareholder who owns more than 10% of the issued and outstanding Common Stock of the Company with the intent to move such Common Stock holdings to treasury for full cancellation thereafter. The transaction involves the repurchase to treasury of the Company of 288,012,618 shares of Common Stock of the Company from TRX Fundco, Inc., an Ontario corporation. The transaction was scheduled to take place Friday, July 22, 2022. Upon closing of the Stock Transaction and the Common Stock Cancellation, the Company will have approximately 1,462,000,000 shares of Common Stock issued and outstanding. The Company may retire an additional up to 100,000,000 shares of Common Stock in other.  

On July 21 HIRU announced 2nd quarter ended revenues of over $2,800,000 USD with a quarterly net profit of $1,359,005 USD. The Company posted its 2nd quarter ended June 30, 2022, Disclosure Statement with OTC Markets, Inc. which included its Financial Statements and Notes thereto. The Company has had over $4,600,000 USD in top line revenue during the first two quarters of 2022 with net profits of over $2,300,000 USD. The 2nd quarter top line revenue beat our 1st quarter by over $1,000,000 USD. The Company expects to beat its predicted annual 2022 top line revenue of $10,000,000 USD at the close of this fiscal year.  

The Company is now reaching its full operational potential which has proven that our decision to dramatically increase its automated water bottling line capabilities last summer was the correct course of action. The Company expects to produce in excess of $4,000,000 USD for the 3rd quarter ended June 30, 2022, and between $6,000,000 USD to $8,000,000 USD for the 4th quarter ended December 31, 2022. That will result in an annual revenue of between $14,000,000 USD to $16,000,000 USD for calendar year ended December 31, 2022.  

Ms. Kathryn Gavin (President and CEO of the Company), states…” We have worked very hard to meet the expectations of our clients and provide proof to them that we can meet all of their water bottling needs on an ongoing basis. We have shown them that we are willing to make major capital investments, on an as needed basis, in our automated water bottling lines to fulfill all their current and requested future needs. These actions have allowed us to solidify our relationship with our long-term clients and attract other large-scale national clients that have requested our co-packing assistance. As such, we are on currently on pace to beat our predicted 2022 revenue expectations by a 50% margin that we previously announced in November of 2021. From a financial performance perspective, we have consistently beaten each quarters revenue expectation for four consecutive quarters while at the same time increasing top line revenue performance in each of these quarters. We fully expect this trend to continue as our long-term clients are steadily increasing their purchase orders and some large new clients, that we have been negotiating with over the past few months, are starting to place large purchase orders as well. We fully expect our 3rd and 4th quarter top line revenue performance to continue this trend through the end of this fiscal year and well into the future. Our co-packing relationship with Alkaline 88 is solid and growing each quarter. We are growing of capabilities to meet their increasing product requirements. We are also continuing to provide product support for the U.S. Border Patrol which we see increasing in the coming months and years. We are also excited to be now working with WaterSourceOne and Walmart in the coming months and years. Our conservative expectations for fiscal year ended December 31, 2023, to be in excess of $30,000,000 USD in top line revenue. As I have been quoted before, the future of the Company is solid and our continued growth in all areas of our business is exciting to say the least.”   

For more on HIRU Subscribe Right Now!

Currently trading at a $10 million market valuation HIRU has 1,748,182,295 shares outstanding and with authorized capped at 1,750,000,000, HIRU cannot issue anymore shares until they raise the authorized share count which takes months. HIRU has a nice-looking balance sheet with over $1 million in cash and manageable debt. On July 21 HIRU announced 2nd quarter ended revenues of over $2,800,000 USD with a quarterly net profit of $1,359,005 USD. Unheard of numbers to be making money on the OTC. The Company is now reaching its full operational potential which has proven that our decision to dramatically increase its automated water bottling line capabilities last summer was the correct course of action. The Company expects to produce in excess of $4,000,000 USD for the 3rd quarter ended June 30, 2022, and between $6,000,000 USD to $8,000,000 USD for the 4th quarter ended December 31, 2022. That will result in an annual revenue of between $14,000,000 USD to $16,000,000 USD for calendar year ended December 31, 2022. HIRU is a really exciting story developing in small caps. A fast-growing Company, already profitable, with no dilution current and an exciting new CEO Kathryn Gavin who is currently in negotiations to acquire several high-profile cash flow positive business operations in the State of Arizona. HIRU has a significant investors base who is heavily accumulating at current levels and are expecting big things here.  We will be updating on HIRU when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in HIRU either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

5 days ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

2 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

3 weeks ago

on

May 14, 2023

By

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.